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Background: Danggui-Jakyak-San (DJS), a traditional herbal prescription, has been used to treat insufficient blood
supplies. Recently, regenerative medication for the treatment of cerebral ischemia has drawn the attention of many
researchers.
Methods: In this study, we examined whether DJS exerts a neuronal regenerative effect in the hippocampus of a
transient forebrain ischemia mice model. Transient forebrain ischemia was induced by bilateral common carotid
artery occlusion (BCCAO). Animals were divided into three groups (sham, BCCAO + vehicle, and BCCAO + DJS). To
test the effect of DJS on learning and memory, Morris water maze or passive avoidance test was conducted. To test
neuroprotective and neurogenic effect, immunohistochemistry and Western blot analysis were used. Statistical
significance was analyzed with Student t-test, one-way or two-way analysis of variance.
Results: We found that the administration of DJS ameliorated ischemia-induced spatial memory impairment in the
Morris water maze task. Moreover, Akt/glycogen synthase kinase-3β (GSK3β)/β-catenin signaling was increased by
DJS, which would be one possible mechanism of DJS for neurogenesis in the hippocampal dentate gyrus region.
Conclusions: These results suggest that DJS is a possible candidate for the treatment of ischemia-induced neuronal
degeneration.
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Neurogenesis in subgranular zone of hippocampus and
the subventricular zone is affected by various physical,
pharmacological, and pathological conditions, specific-
ally including ischemic stroke and seizure [1,2]. Because
of the regional correlation, neurogenesis in the hippo-
campal dentate gyrus (DG) has been studied in various
disorders that cause memory impairment. As a result of
these efforts, many anti-depressants or mood stabilizers
have already been found to improve the neurological
outcomes through an increase in neurogenesis in ischemic* Correspondence: jhryu63@khu.ac.kr; intmed@khu.ac.kr
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reproduction in any medium, provided the orstroke models, including the enhancement of learning and
memory, mood stability, and motor function [3].
Dangui-Jakyak-San (Danggui-Shaoyao-San in Chinese;
Toki-Shakuyaku-San in Japanese; DJS) is an herbal pre-
scription that consists of Paeoniae Radix, Atractylodis
Rhizoma, Alismatis Rhizoma, Hoelen, Cnidii Rhizoma,
and Angelicae Gigantis Radix. DJS has been widely used
in the treatment of various types of diseases [4,5]. Previ-
ous clinical reports demonstrated that DJS has effects on
the mild cognitive impairment [6] and functional deficits
in post-stroke patients [7]. DJS also showed improve-
ments of spatial cognition impairment [8,9] and dys-
function of central cholinergic nervous system [10] in
animal models. Moreover, DJS has neuroprotective ef-
fects in vitro system [11,12]. However, functional mecha-
nisms of the effect of DJS on various neurological
deficits are still not clarified.td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ministration of DJS enhances learning and memory in
normal naïve mice and increases neurogenesis in the
hippocampus. Based on these findings, we speculated
that DJS may improve the functional outcomes in an is-
chemic model through neurogenesis-induced neuronal
regeneration. In a pilot study, the most effective dose of
DJS was 100 mg/kg, and we adopted this dose for fur-
ther experiments. We observed that delayed long-term
treatment with DJS ameliorates the memory impairment
induced by transient forebrain ischemia and that this ef-




Male C57BL/6 mice (22–26 g, 7 weeks) were purchased
from the Orient Co. Ltd, a branch of Charles River La-
boratories (Seoul, Korea), and kept in the University
Animal Care Unit for 1 week prior to the experiments.
The animals were housed 5 per cage, allowed access to
water and food ad libitum; the environment was main-
tained at a constant temperature (23 ± 1°C) and humidity
(60 ± 10%) under a 12-h light/dark cycle (the lights were
on from 07:30 to 19:30 h). Thirty mice were divided
equally into three groups (sham, n = 10; bilateral com-
mon carotid artery occluded ischemia + vehicle, n = 10;
bilateral common carotid artery occluded ischemia +
DJS, n = 10) for behavioral tests. The treatment and
maintenance of the animals were carried out in accord-
ance with the Animal Care and Use Guidelines of Kyung
Hee University, Korea. All of the mouse experiments
were performed according to the protocols approved by
the Institutional Animal Care and Use Committee of
Kyung Hee University (approved protocol numbers:
KHP-2010-6-4; KHP-2010-8-11).
Materials
5-Bromo-2′-deoxyuridine (BrdU) and crezyl violet were
purchased from Sigma Chemical Co. (St. Louis, MO).
Zoletil 50W was obtained from the Virbac laboratory
(06516 Carros, France). The Complete Protease Inhibitor
Cocktail and PhosSTOP Phosphatase Inhibitor Cocktail
were purchased from Roche (Palo Alto, CA). The rat
monoclonal anti-BrdU (ab6326) and rabbit polyclonal
anti-Ki-67 (ab15580) antibodies were purchased from
Abcam (Cambridge, UK). The goat polyclonal anti-
doublecortin (DCX, sc-8066), rabbit polyclonal anti-
Akt (sc-8312), goat polyclonal anti-tubulin (sc-9935),
and goat polyclonal anti-GSK3β (sc-8257) antibodies
were purchased from Santa Cruz Biotech (Santa Cruz,
CA). The mouse monoclonal anti-NeuN (MAB377)
and rabbit monoclonal anti-GFAP (AB5804) antibodies
were purchased from Millipore (Temecula, CA). Therabbit polyclonal anti-pAkt (#9271), anti-pGSK3β (#9323),
and anti-β-catenin (#9582) antibodies were purchased
from Cell Signaling Technology Inc. (Danvers, MA). The
avidin-biotin-peroxidase complex (ABC) kit was pur-
chased from Vector Laboratories, Inc. (Burlingame, CA).
All of the other materials were of the highest grade avail-
able and were obtained from normal commercial sources.
Preparation of herbal extracts
The herbal materials [Paeoniae Radix (Paeonia lactiflora
Pall, Paeoniaceae), Atractylodis Rhizoma (Atractylodes
japonica Koidzmi, Compositae), Alismatis Rhizoma
(Alisma orientalis Juzep, Alismataceae), Hoelen (Poria
cocos Wolf, Polyporaceae), Cnidii Rhizoma (Cnidium
officinale Makino, Umbelliferae), and Angelicae Gigan-
tis Radix (Angelica gigas Nakai, Umbelliferae)] were
purchased from the Kyungdong oriental drug store
(Seoul, Korea) and identified by emeritus professor
Chang Soo Yook, College of Pharmacy, Kyung Hee Uni-
versity. The DJS was prepared by boiling Paeoniae Radix
(4 g), Atractylodis Rhizoma (4 g), Alismatis Rhizoma
(4 g), Hoelen (4 g), Cnidii Rhizoma (3 g), and Angelicae
Gigantis Radix (3 g) in 10 volumes of water. The aque-
ous solutions obtained were filtered, concentrated in a
water bath under vacuum, frozen, lyophilized (Eyela,
model FDU-2000, Japan), and stored at −20°C until
required (yield; 12.3%). Paeoniflorin in Paeoniae Radix,
ferulic acid in Cnidii Rhizoma, and decursin in Angelicae
Gigantis Radix were used to ensure preparation consisten-
cies. Paeoniflorin, ferulic acid, and decursin were present
in DJS at 1.76%, 0.09%, and 0.38%, respectively.
Passive avoidance test
To investigate memory enhancing effects of DJS, the ac-
quisition and retention of passive avoidance behavior
were conducted. The animals underwent two separated
trials, an initial acquisition trial and a retention trial
24 h later. For the acquisition trial, a mouse was initially
placed in the light compartment, and the door between
the two compartments was opened 10 s later. When the
mouse entered the dark compartment, the guillotine
door automatically closed and an electrical foot shock
(0.25 mA, 3 s) was delivered through the floor. For the
retention trial, the mouse was again placed in the light
compartment and the time required to enter the dark
compartment was recorded. Mice were treated with DJS
for 14 days and introduced into the acquisition trial 1 h
after the last administration.
Surgery and drug administration
C57BL/6 mice were anesthetized with 2.0% isoflurane
and 70% nitrous oxide in oxygen and subjected to tran-
sient forebrain ischemia. The transient forebrain ische-
mia was induced by bilateral common carotid artery
Figure 1 The memory enhancing effect of Dangui-Jakyak-San
(DJS). (A) To test memory enhancing effect of DJS, passive avoidance
test was conducted. DJS (50, 100, 200, and 400 mg/kg/day) was
administered for 14 days. Passive avoidance task was conducted 1 h
after the last treatment. Data are presented as mean ± S.E.M
(n = 10/group). *P < 0.05, compared with control group (one-way
ANOVA followed by Student Newman-Keuls’s post-hoc test). (B) In a
separate experiment, BrdU staining was conducted to test effect of DJS
on neurogenesis. Mice were treated with DJS (100 mg/kg/day), and
sacrificed 1 h after the last administration. BrdU was administered
at 13th day (50 mg/kg, i.p., 3 times by 2 h interval). Arrows indicate
immunopositive cells. Data are presented as mean ± S.E.M (n = 6/group).
*P< 0.05, compared with control group (Student t-test). Bar = 50 μm.
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and the circulation was restored by removing the clips.
Mice that received the same surgical operation without
carotid artery clipping served as sham-operated con-
trols. During the surgical procedure, the rectal tem-
perature was maintained at 37 ± 0.5°C with a heating
pad (Biomed S.L., Spain). The regional cerebral blood
flow (rCBF) was monitored using laser Doppler flow-
metry (Perimed, PF5010, JarFalla, Sweden). The mice
that showed between 80% and 95% reduction of rCBF
were used in the study. After reperfusion, the animals
were placed in a warm incubator (32–33°C) and
returned to their home cages. DJS, which was dissolved
in 10% Tween 80 solution, was administered from
7 days to 35 days after BCCAO (100 mg/kg, p.o., once
daily) in the BCCAO + DJS group. BCCAO+ vehicle
group was administered with the same schedule with ve-
hicle (10% Tween 80 solution) instead of DJS.
Morris water maze task
The Morris water maze task was conducted from 30 to
35 days after BCCAO and started 1 h after the adminis-
tration of DJS. The first experimental day was dedicated
to swim training for 60 s in the absence of the platform.
During the four subsequent days, the mice were given
one trial per session per day with the platform in place
to avoid the ceiling effects induced by four trials per ses-
sion. The starting point was changed for each training
trial day. When a mouse located the platform, it was
permitted to remain on it for 10 s. If the mouse did not
locate the platform within 120 s, it was placed on the
platform for 10 s. The animal was taken to its home cage
and was allowed to dry off under an infrared lamp after
each trial. During each trial, the time taken to find the
hidden platform (escape latency) was recorded using a
video camera-based Ethovision System (Nodulus,
Wageningen, The Netherlands). One day after the last
training trial, the mice were subjected to a probe trial
session in which the platform was removed from the
pool, allowing the mice to swim for 120 s to search for
it. A record was kept of the swimming time in the pool
quadrant where the platform had previously been
placed.
BrdU treatment and tissue preparation
Normal naive mice without introduction into BCCAO
were treated with DJS for 14 days, and the mice were
anesthetized with Zoletil 50W (10 mg/kg, i.m.) and then
perfused transcardially with a 100 mM phosphate buffer
(pH 7.4) followed by ice-cold 4% paraformaldehyde. The
brains of the mice were removed and postfixed in a
phosphate buffer (50 mM, pH 7.4) containing 4% para-
formaldehyde overnight, then immersed in a 30% sucrose
solution (in 50 mM phosphate-buffered saline, PBS),and stored at 4°C until sectioned. BrdU (50 mg/kg, i.p.,
3 times by 2 h interval) was administered at 13th day. In
the ischemia experiment, mice were injected with BrdU
(50 mg/kg, i.p., 3 times by 2 h interval) 7 days after
BCCAO. Six mice in each group were anesthetized with
Zoletil 50W (10 mg/kg, i.m.) 35 days after BCCAO, im-
mediately after the probe trial. The perfusion and fix-
ation were conducted as described above. The frozen
brains were coronally sectioned on a cryostat at 30 μm
and then stored in a storage solution (30% ethylene gly-
col, 30% glycerin, and 20 mM phosphate buffer) at 4°C.
Hippocampal sections were collected based on the
mouse brain atlas [13].
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The free-floating sections were incubated for 24 h in PBS
(4°C) containing a rat anti-BrdU antibody (1:500), a rabbit
anti-Ki67 antibody (1:1000) or a goat anti-DCX antibody
(1:500), 0.3% Triton X-100, 0.5 mg/ml bovine serum albu-
min, and 1.5% goat or rabbit serum from the ABC kit. The
sections were then incubated for 90 min with a biotinylated
secondary antibody (1:200), treated with the ABC solution
(1:100) for 1 h at room temperature, and reacted with
0.02% 3, 3′-diaminobenzidine tetrahydrochloride (DAB)
and 0.01% H2O2 for approximately 3 min. After each incu-
bation step, the sections were washed three times with PBS
for 5 min. Finally, the sections were mounted on gelatin-
coated slides, dehydrated in an ascending alcohol series,
and cleared in xylene.
For multiple staining, free-floating sections were
rinsed extensively with PBS (50 mM, pH 7.4) and then
incubated for 30 min in HCl (2 N) at 37°C to denature
DNA. Serial procedures were then conducted as de-
scribed above. The BrdU-labeled cells were visualized
with 0.02% DAB, 0.01% H2O2, and 0.2% nickel ammo-
nium sulfate in 50 mM PBS for approximately 3 min.
The free-floating sections were then incubated for 24 h
in PBS (4°C) containing a rabbit anti-glial fibrillary
acidic protein (GFAP) antibody (1:1000), a mouse anti-
neuronal nuclei (NeuN) antibody (1:1000), or a goat
anti-DCX antibody (1:500), as well as 0.3% Triton X-
100 and 2% donkey serum. The sections were then in-
cubated for 90 min with a FITC- or Cy3-conjugated
secondary antibody (1:200). After each incubation step,
the sections were washed three times with PBS for
5 min, finally, the sections were mounted on gelatin-
coated slides, overlaid with VECTASHIELD mounting
medium, and covered with a coverslip.
Western blot analysis
For the preparation of Western blot samples, four mice
were sacrificed immediately after the probe test of Morris
water maze task, and their isolated hippocampal tissues
were homogenized in an ice-cold Tris–HCl buffer (20 mM,
pH 7.4) containing 0.32 M sucrose, 1 mM EDTA, 1 mM
EGTA, 1 mM PMSF, a Complete Protease Inhibitor Cock-
tail (1 tablet/50 ml) and a PhosSTOP Phosphatase Inhibitor
Cocktail (1 tablet/10 ml). Samples of the homogenates
(20 μg of protein) were then subjected to SDS-PAGE
(8%) under reducing conditions. The proteins were
transferred to PVDF membranes in a transfer buffer
[25 mM Tris–HCl buffer (pH 7.4) containing 192 mM
glycine and 20% v/v methanol] and further separated at
400 mA for 2 h at 4°C. The Western blots were then in-
cubated for 1 h with a blocking solution (5% skim milk),
then with rabbit anti-pAkt, rabbit anti-pGSK3β, or
rabbit anti-β-catenin (1:3000) antibody overnight at 4°C,
washed ten times with Tween 20/Tris-buffered saline(TTBS), incubated with a 1:2000 dilution of horserad-
ish peroxidase-conjugated secondary antibodies for 2 h
at room temperature, washed ten times with TTBS,
and finally developed by enhanced chemiluminescence
(Amersham Life Science, Arlington Heights, IL). The
blots were then stripped and incubated with a rabbit
anti-Akt, rabbit anti-GSK3β or goat anti-tubulin anti-
body (1:5000). The membrane was analyzed with the
bio-imaging program of the LAS-4000 mini (Fujifilm
Lifescience USA, Stamford, CT).
Nissl staining
After the sections were mounted onto gelatin-coated
slides, they were stained with 0.5% cresyl violet, dehy-
drated through graded alcohols (70, 80, 90, and 100% × 2),
placed in xylene, and covered with a coverslip after the
addition of Histomount media.
Quantification and statistical analysis
The number of cells in the hippocampal DG region was
determined using a computerized image analysis system
(Leica Microsystems AG, Wetzlar, Germany). The cells
were counted in 6 sections by every 8 sections interval
(total 48 sections) per animal by a person blind to the
treatment group, and the average cell count per section
was computed. The degree of damage in the hippocam-
pal CA1 by the Nissl staining after ischemia was semi-
quantitatively scored from 0 to 3 (0, normal; 1, < 30% of
the neurons were irreversibly damaged; 2, 30–60% of the
neurons were irreversibly damaged; 3, 60-100% of the
neurons were irreversibly damaged) as described else-
where [14]. The values are expressed as the means ± S.E.
M. The results of histological, immunohistochemical,
and Western blot analyses were analyzed using Student
t-test or one-way analysis of variance (ANOVA) fol-
lowed by Student Newman-Keuls’s post-hoc test for
multiple comparisons. Two-way ANOVA was used to
analyze the data of the path length in the training trials of
the Morris water maze task, and when the results were
significant, Bonferroni’s post-hoc test was used to compare
the treatment groups. The statistical significance was set
at P < 0.05.
Results
DJS enhanced learning and memory in the passive
avoidance test and BrdU incooperation
DJS (100 or 200 mg/kg/day, p.o.)-administered normal
mice showed significant increase in step-through la-
tency during the retention trial of the passive avoid-
ance task (P < 0.05, Figure 1A). However, there were
no significant changes in step-through latency in the
other treated groups (50 or 400 mg/kg). We adopted
100 mg/kg of DJS for further study. Moreover, DJS ad-
ministration (100 mg/kg/day, p.o.) also increased the
Figure 2 The effect of Dangui-Jakyak-San (DJS) on ischemia-induced memory impairment. To test the effect of DJS on ischemia-induced
memory impairment, Morris water maze test was conducted after ischemic injury. Ischemic brain injury was induced by bilateral common carotid
artery occlusion (BCCAO). (A) Experimental schedule. (B-D) The effect of DJS on the Morris water maze task. Path length (B) and swimming speed
(C) were recorded during the training trials. Swimming time in target quadrant which platform was previously existed (D) was recorded in the
probe trial. Data are presented as mean ± S.E.M (n = 10/group). *P < 0.05, compared with sham group. #P < 0.05, compared with BCCAO group
(two-way ANOVA followed by Bonferroni’s post-hoc test for B and C, one-way ANOVA followed by Student Newman-Keuls’s post-hoc test for D).
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DG region (P < 0.05; Figure 1B).
Delayed DJS treatment ameliorated memory impairment
induced by transient forebrain ischemia
As shown in Figure 2B, DJS significantly shortened the
path length (P < 0.05; Figure 2B) in the training trials
without affecting the swimming speed (Figure 2C). In
the probe trial, the swimming times within the target
quadrant in the DJS-treated group were significantly
higher than those in the vehicle-treated control group
(P < 0.05, Figure 2D).
Delayed DJS treatment increased neurogenesis
In neural proliferation, cells positive for Ki67 were sig-
nificantly increased in DJS-treated group compared with
the other groups (P < 0.05, Figure 3A and B). Moreover,
DCX-positive cells were significantly increased by DJS
treatment (P < 0.05, Figure 3A and C). To test whether
DJS has neuroprotective effect, we conducted Nissl
staining of CA1 region which is well known as most vul-
nerable region in ischemic brain [15-17]. However, de-
layed DJS treatment did not protect neuronal injury
induced by BCCAO (P > 0.05, Figure 3A and D), sug-
gesting that effect of DJS is not due to its protectiveeffect. In neuronal differentiation, the DJS-treated
BCCAO group showed significantly higher levels of BrdU-
positive cells (P < 0.05, Figure 3F), BrdU and NeuN-
double-positive cells (P < 0.05, Figure 3E and F), BrdU and
DCX-double-positive cells (P < 0.05, Figure 3E, and F],
and BrdU and GFAP-double-positive cells (P < 0.05,
Figure 3E and 3F) than those of the vehicle-treated BCCAO
or sham groups. In addition, these neuronal differentiation
markers were also slightly increased in the vehicle-treated
BCCAO group. However, the propotions of each neural cell
were not significantly different (Figure 3G).
Delayed DJS treatment activated Akt/GSK3β/β-catenin
signaling
In the hippocampi of the vehicle-treated BCCAO group,
the expression levels of pAkt, pGSK3β, and β-catenin
were not significantly different from those of sham
group. However, DJS treatment significantly increased
these signaling molecules in the hippocampus (P < 0.05,
Figure 4A-D).
Discussion
There is still no successful treatment for massive neurode-
generative diseases such as ischemic stroke. Therefore,
many researchers have been focusing on the regeneration
Figure 3 The effect of Dangui-Jakyak-San (DJS) on ischemia-induced neurogenesis. To test newborn cell survival and neurogenesis, Ki67 or
DCX immunostaining was conducted. (A) Representative of microphotographs of Ki67- and DCX-, and nissl staining-positive cells in the hippocampal
DG region (Bar = 10, 25 or 50 μm). Arrows indicate immunopositive cells. (B) The number of Ki67-immunopositive cells, (C) the number of
DCX-immunopositive cells in the DG, and (D) severity of neuronal damage in the CA1 region were analyzed. (E-G) To test effect of DJS on
ischemia-induced neural differentiation, double-immunostainings were conducted. (E) Representative of microphotographs of BrdU/NeuN-,
BrdU/DCX-, and BrdU/GFAP-immunopositive cells in the hippocampal DG region. Bar = 30 μm. (F) BrDU-immunopositive cells, BrDU/NeuN-
immunopositive cells, BrDU/DCX-immunopositive cells or BrDU/GFAP-immunopositive cells were counted. (G) Proportion of BrdU/NeuN-,
BrdU/DCX-, and BrdU/GFAP-immunopositive cells to BrdU-immunopositive cells in the hippocampal DG region was analyzed. Data are
presented as mean ± S.E.M (n = 6/group). *P < 0.05, compared with sham group. #P < 0.05, compared with BCCAO group (one-way ANOVA
followed by Student Newman-Keuls’s post-hoc test).
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methods utilizing these cells are still under preclinical
study due to insufficient knowledge about their physi-
ology. Recent findings in rodent models of stroke that sug-
gest the replacement of hippocampal pyramidal cells by
endogenous progenitors raise optimism for regenerative
therapies [18]. Before using endogenous neuronal progeni-
tors for the treatment of brain ischemia, several issues
should be addressed. First, to achieve the replacement of
lost neurons, neuronal progenitors should first change the
pathway towards the ischemic lesion, where constitutive
neurogenesis does not normally occur (non-neurogenic
regions). The second issue is that few neurons actually
mature in the lesion, which would account for the diffi-
culty of functional recovery after ischemic injury. It has
also been questioned whether such new neurons become
functionally active. Recently, these issues were addressed
through various experiments. Previous report has already
suggested that treatment with antidepressant and cons-
tituents of ginseng increased ischemic stroke-induced
neurogenesis and improved the functional outcome [3].
Moreover, blockade of neurogenesis in ischemic brain
exacerbates functional deficit [19]. They suggest that the
increase of neurogenesis give a chance to overcome loss of
neurons in ischemic vulnerable region. Therefore, thesefindings suggest that the increase of endogenous neuro-
genesis may be good target for repairing neurodegenera-
tive diseases.
DJS has shown neuroprotective effect in various in vivo
and in vitro conditions [6-12]. However, functional mech-
anisms of the effect of DJS on various neurological deficits
are still not clarified. Previous reports indicated that DJS
regulates neurotransmitters level including acetylcholine
and monoamines, and reduces oxidative damage in vari-
ous brain disease model [8,11,20]. In this study, we found
that delayed long-term administration of DJS improves is-
chemic damage-induced spatial memory impairment. In
addition, DJS significantly increased transient forebrain
ischemia-induced hippocampal neurogenesis and attenu-
ated memory impairment. Moreover, because delayed ad-
ministration with DJS failed to rescue ischemia-induced
neuronal cell death, we suggest that DJS-induced increase
of neurogenesis may be a possible mechanism for func-
tional improvement. However, it was found that DJS did
not affect neuronal differentiation. Further research
should be required to clarify this issue. While DJS showed
its memory enhancing effect at 14-day treatment in nor-
mal naïve mice, it showed its effect at 28-day but not at
14-day treatment in ischemic mice. The reasons of the
differences are unclear, but we speculate that effective
Figure 4 The effect of Dangui-Jakyak-San (DJS) on ischemia-
induced changes of GSK3β signaling. Using Western blot assay,
changes of GSK3β signaling were examined. (A) Representative
photographs of Western blotting. Ratio of pAkt to Akt (B), ratio of pGSK3β
to GSK3β (C), and ratio of β-catenin to tubulin (D) immunoreactivity in
the hippocampal tissue were analyzed. Data are presented as mean ±
S.E.M (n = 4). *P < 0.05, compared with sham group (one-way ANOVA
followed by Student Newman-Keuls’s post-hoc test).
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depends on conditions.
Recently, it has been suggested that GSK3 is a master
regulator of neuronal progenitor homeostasis [21]. Changes
in GSK3β activity occur after cerebral ischemia in regional,
severity of injury, or model dependent manner: increase in
cortical and striatal neurons after global ischemia [22]; de-
creases in the hippocampal CA1 but not CA3 region after
global ischemia [23]. However, GSK3β activity has not been
examined in the neurogenic regions including hippocampal
DG and subventricular zone. In compatible with neurogen-
esis, DJS modulated ischemia-induced changes in Akt/
GSK3β/β-catenin singaling. Appropriate regulation of β-
catenin, which is a downstream molecule of GSK3β, is crit-
ical for the control of progenitior proliferation in various re-
gions of the developing nervous system [24,25]. Therefore,
GSK3β/β-catenin signaling is to be one possible mechanism
for DJS-induced neurogenesis.
Conclusions
Taken together, we propose that post-ischemic prolonged
DJS administration ameliorates the memory impairment
induced by transient forebrain ischemia via an increase ofneurogenesis that is mediated by activation of hippocam-
pal Akt/GSK3β/β-catenin signaling. However, treatment
should be conducted carefully because the effect of DJS is
not promise in higher dose.
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